6533b82cfe1ef96bd128eb8d

RESEARCH PRODUCT

Clinical-pathological characteristics and short-term follow-up associated with proliferation, apoptosis and angiogenesis in a prospective cohort of patients with colorectal tumours.

Rafael FunezJosémaría QuintanaJuan José Borrero MartínIsabel RodrigoAna M BetancourtMaximino RedondoTeresa PeredaAntonio RuedaRafael Cayetano Martínez GarcíaMatilde Sánchez Del CharcoCristina AbiteiRaimundo G. Del MoralRedissec-caressMarilina García-arandaMaría Morales Suárez-varelaFrancisco Rivas-ruizTeresa TéllezAntonio EscobarIñaki Zabalza

subject

0301 basic medicineOncologyAdultMalemedicine.medical_specialtyAngiogenesisApoptosisDisease-Free Survival03 medical and health sciences0302 clinical medicineInternal medicineBiomarkers TumorMedicineHumansProspective cohort studyPathologicalRC254-282AgedCell ProliferationNeovascularization PathologicCell growthbusiness.industryEndoglinColorectal tumourNeoplasms. Tumors. Oncology. Including cancer and carcinogensGeneral MedicineMiddle AgedPrognosis030104 developmental biologyKi-67 AntigenApoptosis030220 oncology & carcinogenesisFemalebusinessColorectal NeoplasmsFollow-Up Studies

description

We investigate the clinical and pathological features related to variations in colorectal tumour apoptosis, proliferation and angiogenesis and the influence of the latter in short-term mortality (2 years); 551 tumour samples from a prospective cohort of patients with colorectal cancer were examined and tumour biology markers were determined as follows: percentage of apoptotic cells, by the terminal deoxynucleotidyl transferase (TdT) dUTP Nick-End Labeling technique; Ki-67 antigen, as a cell proliferation marker and density of microvessels (as a marker of angiogenesis). An increase in the percentage of cellular apoptosis is significantly related to the presence of poorly differentiated tumours, with vascular invasion (p < 0.001). The CD105 angiogenesis marker is not related to any clinical–pathological parameter except that of higher frequency in older patients (p = 0.03). Ki-67 is more frequently expressed in tumours with less nervous invasion (p = 0.05). Neither apoptosis nor angiogenesis present any significant association with short-term survival. The only marker clearly related to 2-year survival is Ki-67, which is shown to be a good prognostic factor in the multivariate analysis (hazard ratio = 0.49; 95% confidence interval = 0.27–0.90). Therefore, in a prospective cohort of colorectal cancer patients, only Ki-67 is a marker of good prognosis in short-term follow-up.

10.1177/1010428319835684https://pubmed.ncbi.nlm.nih.gov/30957671